US Stock MarketDetailed Quotes
EKSO Ekso Bionics
- 0.980
- -0.033-3.29%
Close Aug 14 16:00 ET
- 0.970
- -0.010-1.02%
Post 20:01 ET
18.08MMarket Cap-1240P/E (TTM)
1.050High0.971Low60.35KVolume1.010Open1.013Pre Close60.89KTurnover0.34%Turnover RatioLossP/E (Static)18.44MShares3.12952wk High1.50P/B17.30MFloat Cap0.62052wk Low--Dividend TTM17.66MShs Float863.099Historical High--Div YieldTTM7.80%Amplitude0.620Historical Low1.008Avg Price1Lot Size
Ekso Bionics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 8.03%-2.67M | 17.75%-3.47M | 17.93%-12.05M | 56.53%-1.58M | -29.46%-3.35M | 31.66%-2.9M | -0.19%-4.21M | -31.66%-14.69M | -18.50%-3.64M | -4.65%-2.59M |
| Net income from continuing operations | 42.88%-2.42M | 21.87%-3.43M | -0.78%-15.2M | -1.13%-3.21M | 21.82%-3.37M | -42.04%-4.23M | 5.00%-4.39M | -54.44%-15.08M | -11.00%-3.18M | -119.82%-4.3M |
| Operating gains losses | 104.83%7K | 160.73%116K | 57.85%-279K | 76.68%-316K | -39.84%373K | 48.40%-145K | -153.95%-191K | 84.22%-662K | 21.40%-1.36M | 172.35%620K |
| Depreciation and amortization | -7.24%397K | -1.93%406K | 91.43%1.7M | 161.63%675K | 8.38%181K | 85.28%428K | 79.22%414K | -13.29%887K | 7.05%258K | -40.36%167K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -113.43%-18K | ---21K | --1K |
| Change In working capital | -376.86%-1.08M | -68.20%-952K | 77.40%-583K | 354.60%914K | -478.22%-1.32M | 121.08%389K | 21.93%-566K | -177.42%-2.58M | -224.22%-359K | 154.79%349K |
| -Change in receivables | -157.91%-815K | -5.94%-214K | -1,702.99%-1.21M | 112.60%140K | -351.09%-830K | -357.97%-316K | -115.57%-202K | 95.87%-67K | 31.16%-1.11M | 57.21%-184K |
| -Change in inventory | -22.83%71K | 78.67%-80K | 116.57%232K | 411.69%394K | 147.27%121K | 113.96%92K | 33.27%-375K | -86.17%-1.4M | 113.25%77K | -631.43%-256K |
| -Change in prepaid assets | -687.50%-423K | 126.87%36K | 47.85%-158K | 915.38%212K | -851.22%-308K | 550.00%72K | 55.63%-134K | -1,694.74%-303K | -109.63%-26K | 135.34%41K |
| -Change in payables and accrued expense | 2.46%291K | -93.02%-691K | -381.94%-1.44M | -140.30%-272K | -220.07%-1.1M | 123.36%284K | 46.57%-358K | -115.02%-299K | -70.00%675K | 672.88%912K |
| -Change in other working capital | -178.21%-201K | -100.60%-3K | 489.82%1.99M | 1,592.31%440K | 582.93%792K | 123.48%257K | 203.07%503K | 9.40%-511K | 172.22%26K | 5.75%-164K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 8.03%-2.67M | 17.75%-3.47M | 17.93%-12.05M | 56.53%-1.58M | -29.46%-3.35M | 31.66%-2.9M | -0.19%-4.21M | -31.66%-14.69M | -18.50%-3.64M | -4.65%-2.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 80.95%-8K | 96.97%-157K | 99.15%-43K | 87.94%-17K | -55K | -42K | -8,671.19%-5.18M | -503,500.00%-5.03M | -141K |
| Net PPE purchase and sale | --0 | 80.95%-8K | 10.29%-157K | -26.47%-43K | 87.94%-17K | ---55K | ---42K | -196.61%-175K | -3,500.00%-34K | ---141K |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---5M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 80.95%-8K | 96.97%-157K | 99.15%-43K | 87.94%-17K | ---55K | ---42K | -8,671.19%-5.18M | -503,500.00%-5.03M | ---141K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -265K | 3.66M | 348K | 0 | 0 | 0 | ||||
| Net issuance payments of debt | ---312K | ---313K | ---313K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | --47K | --3.97M | --661K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---265K | --3.66M | --348K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -45.94%8.8M | -57.91%8.64M | -49.20%20.53M | -65.95%9.94M | -58.30%13.31M | -55.01%16.28M | -49.20%20.53M | 214.15%40.41M | -32.83%29.18M | -30.53%31.91M |
| Current changes in cash | 0.78%-2.94M | 104.30%183K | 40.28%-11.86M | 85.26%-1.28M | -23.40%-3.37M | 30.37%-2.96M | -1.19%-4.26M | -172.24%-19.86M | -182.30%-8.68M | -7.73%-2.73M |
| Effect of exchange rate changes | 275.00%21K | -375.00%-22K | -33.33%-24K | -186.96%-20K | --0 | 25.00%-12K | 133.33%8K | -138.30%-18K | -43.90%23K | -102.78%-1K |
| End cash Position | -55.78%5.89M | -45.94%8.8M | -57.91%8.64M | -57.91%8.64M | -65.95%9.94M | -58.30%13.31M | -55.01%16.28M | -49.20%20.53M | -49.20%20.53M | -32.83%29.18M |
| Free cash flow | 9.74%-2.67M | 18.37%-3.47M | 17.95%-12.21M | 55.99%-1.63M | -23.40%-3.37M | 30.37%-2.96M | -1.19%-4.26M | -32.70%-14.88M | -20.27%-3.7M | -7.73%-2.73M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg